{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:12:50Z","timestamp":1787501570344,"version":"build-2736575974"},"reference-count":90,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T00:00:00Z","timestamp":1600905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2020.559673","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T02:29:08Z","timestamp":1600914548000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":36,"title":["Improved Glucocorticoid Receptor Ligands: Fantastic Beasts, but How to Find Them?"],"prefix":"10.3389","volume":"11","author":[{"given":"Laura","family":"Van Moortel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris","family":"Gevaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolien","family":"De Bosscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1073\/pnas.1524215113","article-title":"A trilogy of glucocorticoid receptor actions","volume":"113","author":"Tan","year":"2016","journal-title":"Proc Natl Acad Sci USA."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.jaci.2013.09.007","article-title":"The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease","volume":"132","author":"Oakley","year":"2013","journal-title":"J Allergy Clin Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.rdc.2015.08.002","article-title":"Corticosteroids. mechanisms of action in health and disease","volume":"42","author":"Ramamoorthy","year":"2016","journal-title":"Rheum Dis Clin N Am."},{"key":"B4","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/cen.12728","article-title":"Glucocorticoid receptor function in health and disease","volume":"83","author":"Caratti","year":"2015","journal-title":"Clin Endocrinol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0163-7258(02)00297-8","article-title":"Mechanisms involved in the side effects of glucocorticoids","volume":"96","author":"Sch\u00e4cke","year":"2002","journal-title":"Pharmacol Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.mce.2012.12.014","article-title":"How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering","volume":"380","author":"Ratman","year":"2013","journal-title":"Mol Cell Endocrinol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1210\/me.2008-0283","article-title":"Minireview: latest perspectives on antiinflammatory actions of glucocorticoids","volume":"23","author":"De Bosscher","year":"2009","journal-title":"Mol Endocrinol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1002\/j.1460-2075.1994.tb06726.x","article-title":"A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1","volume":"13","author":"Heck","year":"1994","journal-title":"EMBO J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S0092-8674(00)81183-6","article-title":"DNA binding of the glucocorticoid receptor is not essential for survival","volume":"93","author":"Reichardt","year":"1998","journal-title":"Cell."},{"key":"B10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.pharmthera.2011.12.004","article-title":"Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor","volume":"134","author":"Clark","year":"2012","journal-title":"Pharmacol Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1096\/fj.11-192112","article-title":"Glucocorticoid receptor dimerization is required for survival in septic shock via suppression of interleukin-1 in macrophages","volume":"26","author":"Kleiman","year":"2012","journal-title":"FASEB J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e1001813","DOI":"10.1371\/journal.pbio.1001813","article-title":"Live cell imaging unveils multiple domain requirements for in vivo dimerization of the glucocorticoid receptor","volume":"12","author":"Presman","year":"2014","journal-title":"PLoS Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"8596","DOI":"10.1093\/nar\/gkx509","article-title":"Tethering not required : the glucocorticoid receptor binds directly to activator protein-1 recognition motifs to repress inflammatory genes","volume":"45","author":"Weikum","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1038\/s41467-018-03780-1","article-title":"Cryptic glucocorticoid receptor-binding sites pervade genomic NF-\u03baB response elements","volume":"9","author":"Hudson","year":"2018","journal-title":"Nat Commun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"19244","DOI":"10.1073\/pnas.0705517104","article-title":"Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein-protein interaction profile","volume":"104","author":"Miner","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1210\/en.2007-1353","article-title":"LGD-5552, an antiinflammatory glucocorticoid receptor ligand with reduced side effects, in vivo","volume":"149","author":"L\u00f3pez","year":"2008","journal-title":"Endocrinology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1021\/jm020335m","article-title":"Nonsteroidal selective glucocorticoid modulators: the effect of C-10 substitution on receptor selectivity and functional potency of 5-allyl-2,5-dihydro-2,2,4-trimethyl-lh-[1]benzopyrano[3,4-f]quinolines","volume":"46","author":"Kym","year":"2003","journal-title":"J Med Chem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1210\/me.2002-0355","article-title":"A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effects","volume":"17","author":"Coghlan","year":"2003","journal-title":"Mol Endocrinol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"4481","DOI":"10.1021\/jm010367u","article-title":"Nonsteroidal selective glucocorticoid modulators: the effect of C-5 alkyl substitution on the transcriptional activation\/repression profile of 2,5-dihydro-10-methoxy-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolines","volume":"44","author":"Elmore","year":"2001","journal-title":"J Med Chem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ejphar.2013.12.031","article-title":"The preclinical efficacy, selectivity and pharmacologic profile of MK-5932, an insulin-sparing selective glucocorticoid receptor modulator","volume":"724","author":"Brandish","year":"2014","journal-title":"Eur J Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"7374","DOI":"10.1016\/j.bmc.2011.10.054","article-title":"Discovery of selective glucocorticoid receptor modulator MK-5932","volume":"19","author":"Bungard","year":"2011","journal-title":"Bioorg Med Chem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1111\/bph.12232","article-title":"Discovery of GW870086: a potent anti-inflammatory steroid with a unique pharmacological profile","volume":"169","author":"Uings","year":"2013","journal-title":"Br J Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3109\/02770903.2013.837480","article-title":"Efficacy and safety of once-daily GW870086 a novel selective glucocorticoid in mild-moderate asthmatics: a randomised, two-way crossover, controlled clinical trial","volume":"50","author":"Bareille","year":"2013","journal-title":"J Asthma."},{"key":"B24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000367696","article-title":"Clinical efficacy and tolerability of a novel selective corticosteroid in atopic dermatitis - two randomised controlled trials","volume":"28","author":"D\u00f6lle","year":"2015","journal-title":"Skin Pharmacol Physiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.phrs.2017.09.006","article-title":"Selective glucocorticoid receptor modulation inhibits cytokine responses in a canine model of mild endotoxemia","volume":"125","author":"Bartko","year":"2017","journal-title":"Pharmacol Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1080\/13543784.2019.1599859","article-title":"Clinical profile of the functionally selective glucocorticoid receptor agonist BI 653048 in healthy male subjects","volume":"28","author":"Harcken","year":"2019","journal-title":"Expert Opin Investig Drugs."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1021\/ml500387y","article-title":"Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate","volume":"5","author":"Harcken","year":"2014","journal-title":"ACS Med Chem Lett."},{"key":"B28","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1167\/iovs.09-4202","article-title":"Reduced myocilin expression in cultured monkey trabecular meshwork cells induced by a selective glucocorticoid receptor agonist: comparison with steroids","volume":"51","author":"Pfeffer","year":"2010","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1167\/iovs.10-5598","article-title":"In vivo ocular efficacy profile of mapracorat, a novel selective glucocorticoid receptor agonist, in rabbit models of ocular disease","volume":"52","author":"Shafiee","year":"2011","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/j.1476-5381.2009.00238.x","article-title":"Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases","volume":"158","author":"Sch\u00e4cke","year":"2009","journal-title":"Br J Pharmacol."},{"key":"B31","first-page":"2606","article-title":"BOL-303242-X, a novel selective glucocorticoid receptor agonist, with full anti-inflammatory properties in human ocular cells","volume":"15","author":"Zhang","year":"2009","journal-title":"Mol Vis."},{"key":"B32","first-page":"3208","article-title":"Eosinophil as a cellular target of the ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonist","volume":"17","author":"Baiula","year":"2011","journal-title":"Mol Vis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"745","DOI":"10.2147\/DDDT.S62659","article-title":"Mapracorat, a selective glucocorticoid receptor agonist, causes apoptosis of eosinophils infiltrating the conjunctiva in late-phase experimental ocular allergy","volume":"8","author":"Baiula","year":"2014","journal-title":"Drug Des Devel Ther."},{"key":"B34","first-page":"1791","article-title":"Mapracorat, a novel selective glucocorticoid receptor agonist, inhibits hyperosmolar-induced cytokine release and MAPK pathways in human corneal epithelial cells","volume":"16","author":"Cavet","year":"2010","journal-title":"Mol Vis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.exer.2014.07.013","article-title":"Mapracorat, a selective glucocorticoid receptor agonist, upregulates RelB, an anti-inflammatory nuclear factor-kappaB protein, in human ocular cells","volume":"127","author":"Spinelli","year":"2014","journal-title":"Exp Eye Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"35212","DOI":"10.1074\/jbc.M112.400671","article-title":"Anti-inflammatory effects of mapracorat, a novel selective glucocorticoid receptor agonist, is partially mediated by MAP kinase phosphatase-1 (MKP-1)","volume":"287","author":"Vollmer","year":"2012","journal-title":"J Biol Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1210\/en.2010-1447","article-title":"The antagonists but not partial agonists of glucocorticoid receptor ligands show substantial side effect dissociation","volume":"152","author":"Hu","year":"2011","journal-title":"Endocrinology."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e000889","DOI":"10.1136\/rmdopen-2018-000889","article-title":"Fosdagrocorat (PF-04171327) versus prednisone or placebo in rheumatoid arthritis: a randomised, double-blind, multicentre, phase IIb study","volume":"5","author":"Buttgereit","year":"2019","journal-title":"RMD Open."},{"key":"B39","unstructured":"HemmerlingM\n            NilssonS\n          Selective Nonsteroidal Glucocorticoid Receptor Modulators for the Inhaled Treatment of Pulmonary Diseases | Journal of Medicinal Chemistry2017"},{"key":"B40","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/bcpt.12768","article-title":"Efficacy and tolerability of an inhaled selective glucocorticoid receptor modulator \u2013 AZD5423 \u2013 in chronic obstructive pulmonary disease patients: Phase II study results","volume":"121","author":"Kuna","year":"2017","journal-title":"Basic Clin Pharmacol Toxicol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1164\/rccm.201404-0623OC","article-title":"A nonsteroidal glucocorticoid receptor agonist inhibits allergen-induced late asthmatic responses","volume":"191","author":"Gauvreau","year":"2014","journal-title":"Am J Respir Crit Care Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12931-019-1000-7","article-title":"Efficacy and safety of AZD7594, an inhaled non-steroidal selective glucocorticoid receptor modulator, in patients with asthma: a phase 2a randomized, double blind, placebo-controlled crossover trial","volume":"20","author":"Brown","year":"2019","journal-title":"Respir Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1021\/acs.jmedchem.7b01690","article-title":"Discovery of a novel oral glucocorticoid receptor modulator (AZD9567) with improved side effect profile","volume":"61","author":"Ripa","year":"2018","journal-title":"J Med Chem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2153-2435.1000560","article-title":"In vivo studies for drug development via oral delivery: challenges, animal models and techniques","volume":"8","author":"Brake","year":"2017","journal-title":"Pharm Anal Acta."},{"key":"B45","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/cts.12577","article-title":"The current status of drug discovery and development as originated in United States academia: the influence of industrial and academic collaboration on drug discovery and development","volume":"11","author":"Takebe","year":"2018","journal-title":"Clin Transl Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/14740338.2016.1240783","article-title":"Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis","volume":"15","author":"Minozzi","year":"2016","journal-title":"Expert Opin Drug Saf."},{"key":"B47","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11910-017-0742-1","article-title":"CNS demyelination with TNF-\u03b1 blockers","volume":"17","author":"Kemanetzoglou","year":"2017","journal-title":"Curr Neurol Neurosci Rep."},{"key":"B48","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1136\/annrheumdis-2015-208490","article-title":"Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish multiple sclerosis registry","volume":"75","author":"Dreyer","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1756286419895155","DOI":"10.1177\/1756286419895155","article-title":"PPMS onset upon adalimumab treatment extends the spectrum of anti-TNF-\u03b1 therapy-associated demyelinating disorders","volume":"13","author":"Engel","year":"2020","journal-title":"Ther Adv Neurol Disord."},{"key":"B50","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1684\/ejd.2015.2558","article-title":"Multiple neurological abnormalities, including pontine hemorrhage, multiple sclerosis and aseptic meningitis, during anti-TNF-\u03b1 therapy in psoriatic arthritis","volume":"25","author":"Honda","year":"2015","journal-title":"Eur J Dermatol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1212\/01.wnl.0000406608.85830.82","article-title":"TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study","volume":"77","year":"2011","journal-title":"Neurology."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1212\/WNL.47.6.1531","article-title":"Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2","volume":"47","author":"van Oosten","year":"1996","journal-title":"Neurology."},{"key":"B53","unstructured":"Global Surveillance, Prevention and Control of Chronic Respiratory Diseases2007"},{"key":"B54","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s40120-019-00156-5","article-title":"Treatment effectiveness for resolution of multiple sclerosis relapse in a US health plan population","volume":"8","author":"Nazareth","year":"2019","journal-title":"Neurol Ther."},{"key":"B55","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00277-018-3465-8","article-title":"Glucocorticoids in multiple myeloma: past, present, and future","volume":"98","author":"Burwick","year":"2019","journal-title":"Ann Hematol."},{"key":"B56","unstructured":"Global Initiative for Asthma - GINAGlobal Strategy for Asthma Management and Prevention2019"},{"key":"B57","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/ajd.12313","article-title":"Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statement","volume":"56","author":"Mooney","year":"2015","journal-title":"Australas J Dermatol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/ajd.12292","article-title":"Ocular side\u2013effects of topical corticosteroids: what a dermatologist needs to know","volume":"56","author":"Daniel","year":"2015","journal-title":"Australas J Dermatol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/ijd.13485","article-title":"Methylprednisolone aceponate for atopic dermatitis","volume":"56","author":"Torrelo","year":"2017","journal-title":"Int J Dermatol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/j.ophtha.2018.04.035","article-title":"Adrenal suppression in infants treated with topical ocular glucocorticoids","volume":"125","author":"Bangsgaard","year":"2018","journal-title":"Ophthalmology."},{"key":"B61","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/S2213-2600(18)30058-4","article-title":"Susceptibility to corticosteroid-induced adrenal suppression: a genome-wide association study","volume":"6","author":"Hawcutt","year":"2018","journal-title":"Lancet Respir Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.chest.2017.07.002","article-title":"Long-term use of inhaled corticosteroids in COPD and the risk of fracture","volume":"153","author":"Gonzalez","year":"2018","journal-title":"Chest."},{"key":"B63","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.anai.2016.07.043","article-title":"Inhaled corticosteroids: effects on growth and bone health","volume":"117","author":"Skoner","year":"2016","journal-title":"Ann Allergy Asthma Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.yapd.2017.03.006","article-title":"Effects of inhaled corticosteroids on growth, bone metabolism, and adrenal function","volume":"64","author":"Wolfgram","year":"2017","journal-title":"Adv Pediatr."},{"key":"B65","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s12104-018-9820-9","article-title":"Backbone 1H, 13C, and 15N resonance assignments of the ligand binding domain of the human wildtype glucocorticoid receptor and the F602S mutant variant","volume":"12","author":"K\u00f6hler","year":"2018","journal-title":"Biomol NMR Assign."},{"key":"B66","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nrm.2016.152","article-title":"Glucocorticoid receptor control of transcription: precision and plasticity via allostery","volume":"18","author":"Weikum","year":"2017","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"19940","DOI":"10.1038\/srep19940","article-title":"Allosteric pathways in the PPAR\u03b3-RXR\u03b1 nuclear receptor complex","volume":"6","author":"Ricci","year":"2016","journal-title":"Sci Rep."},{"key":"B68","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1126\/science.1164265","article-title":"DNA binding site sequence directs glucocorticoid receptor structure and activity","volume":"324","author":"Meijsing","year":"2009","journal-title":"Science."},{"key":"B69","doi-asserted-by":"publisher","first-page":"6142","DOI":"10.1093\/nar\/gkw203","article-title":"Identification and characterization of DNA sequences that prevent glucocorticoid receptor binding to nearby response elements","volume":"44","author":"Telorac","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"12621","DOI":"10.1038\/ncomms12621","article-title":"Sequences flanking the core-binding site modulate glucocorticoid receptor structure and activity","volume":"7","author":"Sch\u00f6ne","year":"2016","journal-title":"Nat Commun."},{"key":"B71","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1530\/EJE-11-0751","article-title":"Prednisone affects inflammation, glucose tolerance, and bone turnover within hours of treatment in healthy individuals","volume":"166","author":"Kauh","year":"2012","journal-title":"Eur J Endocrinol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/j.1365-2885.2010.01174.x","article-title":"Bone demineralization in the lumbar spine of dogs submitted to prednisone therapy","volume":"33","author":"Costa","year":"2010","journal-title":"J Vet Pharmacol Ther."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1172\/JCI88886","article-title":"Glucocorticoid receptors : finding the middle ground","volume":"127","author":"Desmet","year":"2017","journal-title":"J Clin Invest."},{"key":"B74","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1128\/MCB.10.9.4712","article-title":"Characterization of a complex glucocorticoid response unit in the phosphoenolpyruvate carboxykinase gene","volume":"10","author":"Imai","year":"1990","journal-title":"Mol Cell Biol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0014-5793(96)00224-4","article-title":"Cloning and sequencing of the 5\u2032 region of the human glucose-6-phosphatase gene: transcriptional regulation by cAMP, insulin and glucocorticoids in H4IIE hepatoma cells","volume":"383","author":"Schmoll","year":"1996","journal-title":"FEBS Lett."},{"key":"B76","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s13075-016-1187-7","article-title":"Smad-dependent mechanisms of inflammatory bone destruction","volume":"18","author":"Fennen","year":"2016","journal-title":"Arthritis Res Ther."},{"key":"B77","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/jcp.25399","article-title":"Glucocorticoids Hijack Runx2 to stimulate Wif1 for suppression of osteoblast growth and differentiation","volume":"232","author":"Morimoto","year":"2017","journal-title":"J Cell Physiol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.cmet.2011.01.001","article-title":"Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle","volume":"13","author":"Shimizu","year":"2011","journal-title":"Cell Metab."},{"key":"B79","doi-asserted-by":"publisher","first-page":"42","DOI":"10.15252\/emmm.201404601","article-title":"REDD1 functions at the crossroads between the therapeutic and adverse effects of topical glucocorticoids","volume":"7","author":"Baida","year":"2015","journal-title":"EMBO Mol Med."},{"key":"B80","doi-asserted-by":"publisher","first-page":"E983","DOI":"10.1152\/ajpendo.00234.2014","article-title":"REDD1 deletion prevents dexamethasone-induced skeletal muscle atrophy","volume":"307","author":"Britto","year":"2014","journal-title":"AJP Endocrinol Metab."},{"key":"B81","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.bbrc.2015.03.049","article-title":"Indole-3-carbinol as inhibitors of glucocorticoid-induced apoptosis in osteoblastic cells through blocking ROS-mediated Nrf2 pathway","volume":"460","author":"Lin","year":"2015","journal-title":"Biochem Biophys Res Commun."},{"key":"B82","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.bone.2017.01.014","article-title":"Silencing miR-106b accelerates osteogenesis of mesenchymal stem cells and rescues against glucocorticoid-induced osteoporosis by targeting BMP2","volume":"97","author":"Liu","year":"2017","journal-title":"Bone."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1136\/annrheumdis-2015-207240","article-title":"Inactivation of autophagy ameliorates glucocorticoid-induced and ovariectomy-induced bone loss","volume":"75","author":"Lin","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"B84","doi-asserted-by":"publisher","first-page":"e8063","DOI":"10.1038\/s41598-017-07941-y","article-title":"Compound A influences gene regulation of the Dexamethasone- activated glucocorticoid receptor by alternative cofactor recruitment","volume":"7","author":"Desmet","year":"2017","journal-title":"Sci Rep."},{"key":"B85","doi-asserted-by":"publisher","first-page":"15440","DOI":"10.1038\/s41598-017-15549-5","article-title":"Site-specific phosphorylation regulates the structure and function of an intrinsically disordered domain of the glucocorticoid receptor","volume":"7","author":"Khan","year":"2017","journal-title":"Sci Rep."},{"key":"B86","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00405-016-4331-8","article-title":"Effect of a liposomal hyaluronic acid gel loaded with dexamethasone in a guinea pig model after manual or motorized cochlear implantation","volume":"274","author":"Mamelle","year":"2017","journal-title":"Eur Arch Otorhinolaryngol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1089\/jop.2017.0099","article-title":"Characterization and pharmacokinetics of triamcinolone acetonide-loaded liposomes topical formulations for vitreoretinal drug delivery","volume":"34","author":"Altamirano-Vallejo","year":"2018","journal-title":"J Ocul Pharmacol Ther."},{"key":"B88","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jconrel.2019.01.028","article-title":"Liposomal dexamethasone inhibits tumor growth in an advanced human-mouse hybrid model of multiple myeloma","volume":"296","author":"Deshantri","year":"2019","journal-title":"J Controlled Release."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.2217\/nnm-2018-0501","article-title":"Peptide-targeted liposomal delivery of dexamethasone for arthritis therapy","volume":"14","author":"Meka","year":"2019","journal-title":"Nanomed."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1177\/0961203316636468","article-title":"A liposomal steroid nano-drug for treating systemic lupus erythematosus","volume":"25","author":"Moallem","year":"2016","journal-title":"Lupus."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.559673\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T02:29:17Z","timestamp":1600914557000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.559673\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,24]]},"references-count":90,"alternative-id":["10.3389\/fendo.2020.559673"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.559673","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,24]]},"article-number":"559673"}}